All News
Filter News
Found 808,679 articles
-
Medtronic Venous Stent Receives U.S. FDA Approval to Treat Venous Outflow Obstruction
10/26/2020
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) approval for the Abre™ venous self-expanding stent system. This device is
-
Ginkgo Bioworks Secures Access to SARS-CoV-2 Rapid Antigen Test With Goal of Acquiring and Distributing Up To 50 Million Tests
10/26/2020
Today, Ginkgo Bioworks announced it has secured access to the SD Biosensor rapid antigen test with a goal of acquiring and distributing up to 50 million tests. Concentric by Ginkgo , the company's CO
-
New Records Set for Organ Donation and Transplantation Despite Pandemic
10/26/2020
Despite the COVID-19 pandemic – and with more than two months remaining in 2020 – a record number of Hoosier organ donors have already given the gift of life through Indiana Donor Network, resulting in a record number of lifesaving organs transplanted in a single calendar year.
-
Immunovia Announces Completion of Analysis from the IMMray™ PanCan-d Verification Study
10/26/2020
Additional Sample Collection for Validation Study Hindered due to COVID-19 Infection Rate Increase, Causes Delay in Sales Launch
-
T-Cells from recovered COVID-19 patients show promise to protect vulnerable patients from infection
10/26/2020
T-cells taken from the blood of people who recovered from a COVID-19 infection can be successfully multiplied in the lab and maintain the ability to effectively target proteins that are key to the virus's function, according to a new study published Oct. 26 in Blood.
-
Bob Gallagher Joins OneOncology as Chief Operations Officer
10/26/2020
- OneOncology, the national partnership of independent oncology practices, today announced that Bob Gallagher has been appointed Chief Operations Officer overseeing all operations functions for the high-growth community-based oncology platform. Before coming to OneOncology, Gallagher was a division vice president at DaVita, a nat
-
ISOThrive Awarded $800K Virginia Catalyst Grant to address major unmet need in gastroesophageal reflux disease (GERD) treatment and drive economic growth in Virginia
10/26/2020
ISOThrive Inc. has been awarded $800,000 from Virginia Catalyst to advance its microbiome therapeutic for Gastroesophageal Reflux Disease (GERD).
-
BioCanna Announces A Breakthrough In Development of Its Patent-Pending 'BioNano Virus Detection System' And Announcing the COVID-19 POC Test Kit
10/26/2020
BioCanna Health Care Inc., a leading innovator in pharmaceutical applications of Cannabinoids, Terpenes and other biomaterials, has announced that its wholly owned subsidiary, BioCanna CuraLab, in collaboration with University of Ottawa , has made a breakthrough development in its "BioNano Virus Detection System" by innovative a
-
Study: Poverty Linked to Higher Risk of Death Among Children with Cancer Undergoing Stem Cell Transplantation
10/26/2020
Despite the increasing use and promise of hematopoietic cell transplantation (HCT) as curative therapy for children with cancer and other life-threatening diseases, new research suggests that children transplanted for cancer are more likely to die from treatment-related complications if they live in poorer neighborhoods.
-
SeaStar Medical Announces Positive Results from Pilot Clinical Study of the Selective Cytopheretic Device (SCD) in Pediatric Patients with Acute Kidney Injury
10/26/2020
SeaStar Medical, a medical technology company delivering novel therapeutic immunomodulating solutions to improve organ function, today announced the results from the first every application of the Selective Cytopheretic Device (SCD) in pediatric patients with acute kidney injury (AKI) requiring continuous renal replacement therapy (CRRT).
-
Avidity Science™ Expands Biomedical Research Solutions Through Acquisition of Bio Medic Data Systems, Hydropac®, Lab Products, Inc., and Harford Systems
10/26/2020
Today, Avidity Science announces significant steps in expanding its global leadership in biomedical research solutions via the acquisition of Bio Medic Data Systems, Hydropac®, Lab Products, Inc., and Harford Systems. These investments expand Avidity's portfolio of water purification and delivery products, control and monitoring s
-
Ampio Presents at Roth Capital Partners 2020 MedTech Innovation Forum Focusing on COVID-19 Clinical Trial Activities
10/26/2020
Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology based therapies for prevalent inflammatory conditions, announced today that the Company will present at the 2020 MedTech Innovation Forum hosted by Roth Capital Partners on Wednesday, October 28, 2020.
-
Statement from the Chief Public Health Officer of Canada on October 26, 2020
10/26/2020
In lieu of an in-person update to the media, Dr. Theresa Tam , Canada's Chief Public Health Officer, issued the following statement today: "As the resurgence of COVID-19 activity continues in Canada , we are tracking a range of epidemiological indicators to monitor where the disease is most active, where it is spreading and how i
-
Study in Nature Medicine Shows Superior Outcomes for Patients in The Leukemia & Lymphoma Society's Paradigm-Shifting Beat AML Clinical Trial
10/26/2020
Patients participating in The Leukemia & Lymphoma Society's (LLS) groundbreaking precision medicine Beat AML Master Clinical Trial had superior outcomes compared to acute myeloid leukemia (AML) patients who opted for standard chemotherapy treatment, according to findings published today in the prestigious Nature Medicine
-
AscellaHealth Earns Merit-Based Philadelphia100 Award as Seventh Among the Fastest Growing, Privately Held Companies in the Greater Philadelphia Region
10/26/2020
AscellaHealth, a national specialty pharmacy benefit manager (SPBMTM) serving commercial, Medicare and Medicaid segments, announces today that it has won the prestigious Philadelphia100 award as 7th among 100 of the fastest growing privately held entrepreneurial companies in the Greater Philadelphia Region.
-
New Greenphire Data Indicates Clinical Trial Industry's Swift Rebound; Patient Enrollment Reaches Pre-Pandemic Levels
10/26/2020
Greenphire, the global leader in financial lifecycle management for clinical trials, says patient enrollment for global clinical trials has returned to pre-COVID levels.
-
Fabric Genomics to Co-market Comprehensive Sample-to-Genomic Analysis Sequencing Solutions for Hereditary Genetics
10/26/2020
In a step toward the full realization of genomic medicine, Fabric Genomics, a leader in AI-based genomic analysis and interpretation, has announced a co-marketing agreement that will provide translational researchers around the world with integrated sample prep to reporting workflows. Combining Roche’s newly released KAPA HyperExome Probes (RUO) with the Fabric Enterprise bioinformatics and analysis platform will make ge
-
Vigene Strengthens Management Team with Another Key Executive Addition as Business Expansion Continues
10/26/2020
Vigene Biosciences, an award-winning world leader in plasmid and viral vector development and manufacturing, announces today another key executive addition. Audrey Chang, Ph.D. is appointed as the VP of QC and Analytical Services.
-
Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19
10/26/2020
Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“U.S. FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild-moderate COVID-19.
-
BioSkryb’s Novel PTA Technology for High-Quality Single-Cell Whole Genome Amplification Will Be Commercially Available for the First Time at ASHG 2020
10/26/2020
BioSkryb, Inc., a developer of genomic amplification technologies, today announced the commercial launch of ResolveDNATM products to accurately and uniformly reproduce genomes of single cells.